NO20085265L - Nye forbindelser som har affinitet for amyloid - Google Patents
Nye forbindelser som har affinitet for amyloidInfo
- Publication number
- NO20085265L NO20085265L NO20085265A NO20085265A NO20085265L NO 20085265 L NO20085265 L NO 20085265L NO 20085265 A NO20085265 A NO 20085265A NO 20085265 A NO20085265 A NO 20085265A NO 20085265 L NO20085265 L NO 20085265L
- Authority
- NO
- Norway
- Prior art keywords
- carbon
- amyloid
- affinity
- halogen substituent
- salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/22—Tin compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/22—Tin compounds
- C07F7/2208—Compounds having tin linked only to carbon, hydrogen and/or halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006140044 | 2006-05-19 | ||
| JP2006324701 | 2006-11-30 | ||
| PCT/JP2007/059922 WO2007135890A1 (fr) | 2006-05-19 | 2007-05-15 | Composé innovant ayant une affinité pour la substance amyloïde |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20085265L true NO20085265L (no) | 2009-02-18 |
Family
ID=38723203
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20085265A NO20085265L (no) | 2006-05-19 | 2008-12-16 | Nye forbindelser som har affinitet for amyloid |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US8303935B2 (fr) |
| EP (1) | EP2019103B1 (fr) |
| JP (1) | JP5238496B2 (fr) |
| KR (1) | KR20090010987A (fr) |
| AT (1) | ATE535527T1 (fr) |
| AU (1) | AU2007252658B2 (fr) |
| BR (1) | BRPI0711818A2 (fr) |
| CA (1) | CA2653783A1 (fr) |
| ES (1) | ES2376491T3 (fr) |
| IL (4) | IL195378A0 (fr) |
| NO (1) | NO20085265L (fr) |
| NZ (1) | NZ573363A (fr) |
| RU (1) | RU2008150377A (fr) |
| TW (1) | TW200808795A (fr) |
| WO (1) | WO2007135890A1 (fr) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200803903A (en) | 2006-04-28 | 2008-01-16 | Nihon Mediphysics Co Ltd | Novel compound having affinity to amyloid |
| TW200808795A (en) | 2006-05-19 | 2008-02-16 | Nihon Mediphysics Co Ltd | Novel compound having affinity for amyloid |
| TW200811175A (en) * | 2006-06-21 | 2008-03-01 | Nihon Mediphysics Co Ltd | Novel compound with affinity with amyloid |
| KR20090025282A (ko) * | 2006-06-21 | 2009-03-10 | 니혼 메디피직스 가부시키가이샤 | 신규 아밀로이드 친화성 화합물 |
| US20100056826A1 (en) * | 2006-11-09 | 2010-03-04 | Nihon Medi-Physicis Co., Ltd. | Radioactive diagnostic imaging agent |
| WO2008059714A1 (fr) * | 2006-11-17 | 2008-05-22 | Nihon Medi-Physics Co., Ltd. | Composés inédits présentant une affinité pour la substance amyloïde |
| US8207189B2 (en) | 2006-11-30 | 2012-06-26 | Nihon Medi-Physics Co., Ltd. | Compound having affinity for amyloid |
| KR101485445B1 (ko) | 2007-02-13 | 2015-01-22 | 니혼 메디피직스 가부시키가이샤 | 방사성 화상진단제의 제조 방법 |
| EP2213672A4 (fr) * | 2007-10-24 | 2012-05-02 | Nihon Mediphysics Co Ltd | Nouveau composé possédant une affinité vis-à-vis d'une substance amyloïde |
| EP2213671A4 (fr) * | 2007-10-26 | 2012-02-22 | Nihon Mediphysics Co Ltd | Nouveau composé présentant une affinité pour l'amyloïde |
| WO2009057576A1 (fr) * | 2007-10-30 | 2009-05-07 | Nihon Medi-Physics Co., Ltd. | Utilisation d'un nouveau composé présentant une affinité pour les substances amyloïdes et procédé de production dudit composé |
| CA2704139A1 (fr) * | 2007-10-30 | 2009-05-07 | Nihon Medi-Physics Co., Ltd. | Utilisation de nouveaux composes a affinite pour les substances amyloides et leur procede de production |
| KR20100101576A (ko) * | 2007-10-30 | 2010-09-17 | 니혼 메디피직스 가부시키가이샤 | 신규 아밀로이드 친화성 화합물의 사용 및 제조 방법 |
| EP2218464A1 (fr) * | 2009-02-11 | 2010-08-18 | Technische Universität München | Composés pour la mesure non invasive d'agrégats de peptides amyloïdes |
| WO2011108236A1 (fr) * | 2010-03-01 | 2011-09-09 | 日本メジフィジックス株式会社 | Composé organique marqué à l'iode radioactif ou sel de ce composé |
| KR20140040722A (ko) * | 2011-05-20 | 2014-04-03 | 니혼 메디피직스 가부시키가이샤 | 신규 아밀로이드 친화성 화합물 |
| CA2839199C (fr) | 2011-06-24 | 2018-11-06 | Nihon Medi-Physics Co., Ltd. | Nouveau compose ayant une affinite pour l'amyloide |
| HUE033612T2 (en) | 2013-05-23 | 2017-12-28 | Hoffmann La Roche | 2-Phenylimidazo [1,2-a] pyrimidines as imaging agents |
| SG11201908066XA (en) * | 2017-03-07 | 2019-09-27 | Nihon Mediphysics Co Ltd | Radioactive fluorine-labeled precursor compound, and method for producing radioactive fluorine-labeled compound using same |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4791117A (en) | 1986-09-22 | 1988-12-13 | Ortho Pharmaceutical Corporation | 2- or 3-aryl substituted imidazo[1,2-a]pyridines and their use as calcium channel blockers |
| US4833149A (en) | 1986-09-22 | 1989-05-23 | Ortho Pharmaceutical Corporation | 2- or 3-aryl substituted imidazo[1,2-a]pyridines |
| US4871745A (en) | 1986-09-22 | 1989-10-03 | Ortho Pharmaceutical Corporation | 2- or 3-aryl substituted imidazo(1,2-A)pyridines and their use as antisecretory agents |
| US4727145A (en) * | 1986-09-22 | 1988-02-23 | Ortho Pharmaceutical Corporation | 2- Or 3- aryl substituted imidazo [1,2-a]pyridines |
| DE4327027A1 (de) | 1993-02-15 | 1994-08-18 | Bayer Ag | Imidazoazine |
| JP2000510816A (ja) | 1995-10-17 | 2000-08-22 | ジー.ディー.サール アンド カンパニー | シクロオキシゲナーゼ−2の検出法 |
| US6812327B1 (en) | 1996-10-25 | 2004-11-02 | Human Genome Sciences, Inc. | Neutrokine-alpha polypeptides |
| US6274119B1 (en) | 1998-08-20 | 2001-08-14 | The Regents Of The Univ. Of California | Methods for labeling β-amyloid plaques and neurofibrillary tangles |
| JP4025468B2 (ja) | 1999-07-29 | 2007-12-19 | 三井化学株式会社 | 有機電界発光素子 |
| AU2001249679A1 (en) | 2000-03-31 | 2001-10-15 | Ortho-Mcneil Pharmaceutical, Inc. | Phenyl-substituted imidazopyridines |
| US20010051632A1 (en) | 2000-03-31 | 2001-12-13 | Wenying Chai | Phenyl-substituted indolizines and tetrahydroindolizines |
| AU2001249672A1 (en) * | 2000-03-31 | 2001-10-15 | Ortho-Mcneil Pharmaceutical, Inc. | Method for using 2- or 3-aryl substituted imidazo(1,2-a) pyridines as h3 antagonists |
| DE10040016A1 (de) * | 2000-08-16 | 2002-02-28 | Boehringer Ingelheim Pharma | Neue beta-Amyloid Inhibitoren, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
| US6514969B2 (en) | 2000-08-16 | 2003-02-04 | Boehringer Ingelheim Pharma Kg | β-amyloid inhibitors, processes for preparing them, and their use in pharmaceutical compositions |
| ES2395721T3 (es) | 2000-08-24 | 2013-02-14 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Derivados de tioflavina y su uso en diagnosis y terapia de la enfermedad de alzheimer |
| BR0207315A (pt) | 2001-02-26 | 2004-02-10 | Bristol Myers Squibb Pharma Co | Análogos de ácido ascórbico para metalorradiofármacos |
| US6596731B2 (en) | 2001-03-27 | 2003-07-22 | Hoffmann-La Roche Inc. | Substituted imidazo[1,2-A] pyridine derivatives |
| CN100422180C (zh) | 2001-04-23 | 2008-10-01 | 宾夕法尼亚州大学理事会 | 淀粉样斑块聚集抑制剂和诊断成像剂 |
| EP1401836B1 (fr) | 2001-06-21 | 2006-08-23 | SmithKline Beecham Corporation | Derives d'imidazo¬1,2-a|pyridine destines a la prevention et au traitement d'infections au virus de l'herpes |
| CN101003526B (zh) | 2001-08-27 | 2012-02-22 | 宾夕法尼亚州大学理事会 | 茋衍生物及其用于结合和成像淀粉样蛋白斑的用途 |
| GB0205281D0 (en) | 2002-03-06 | 2002-04-17 | Novartis Ag | Organic compounds |
| AU2003242233A1 (en) | 2002-06-12 | 2003-12-31 | Bf Research Institute, Inc. | Probe compound for image diagnosis of disease with amyloid accumulation, compound for staining age spots/diffuse age spots, and remedy for disease with amyloid accumulation |
| JPWO2004035522A1 (ja) * | 2002-08-30 | 2006-02-16 | 株式会社 ビーエフ研究所 | プリオン蛋白蓄積性疾患の診断プローブおよび治療薬ならびにプリオン蛋白の染色剤 |
| JP2006505610A (ja) | 2002-11-05 | 2006-02-16 | イヨン ベアム アプリカスィヨン エッス.アー. | 18−f標識放射性製剤の安定化 |
| EP1699799B1 (fr) | 2003-12-31 | 2007-05-16 | Schering-Plough Ltd. | Lutte contre les parasites chez des animaux, a l aide de der ives d imidazo [1,2-b] pyridazine |
| TW200803903A (en) | 2006-04-28 | 2008-01-16 | Nihon Mediphysics Co Ltd | Novel compound having affinity to amyloid |
| TW200808795A (en) | 2006-05-19 | 2008-02-16 | Nihon Mediphysics Co Ltd | Novel compound having affinity for amyloid |
| KR20090025282A (ko) * | 2006-06-21 | 2009-03-10 | 니혼 메디피직스 가부시키가이샤 | 신규 아밀로이드 친화성 화합물 |
| EP2213672A4 (fr) | 2007-10-24 | 2012-05-02 | Nihon Mediphysics Co Ltd | Nouveau composé possédant une affinité vis-à-vis d'une substance amyloïde |
| EP2213671A4 (fr) | 2007-10-26 | 2012-02-22 | Nihon Mediphysics Co Ltd | Nouveau composé présentant une affinité pour l'amyloïde |
| CA2704139A1 (fr) | 2007-10-30 | 2009-05-07 | Nihon Medi-Physics Co., Ltd. | Utilisation de nouveaux composes a affinite pour les substances amyloides et leur procede de production |
-
2007
- 2007-05-15 TW TW096117253A patent/TW200808795A/zh unknown
- 2007-05-15 KR KR1020087028172A patent/KR20090010987A/ko not_active Withdrawn
- 2007-05-15 JP JP2008516608A patent/JP5238496B2/ja not_active Expired - Fee Related
- 2007-05-15 BR BRPI0711818-0A patent/BRPI0711818A2/pt not_active IP Right Cessation
- 2007-05-15 US US12/227,487 patent/US8303935B2/en not_active Expired - Fee Related
- 2007-05-15 WO PCT/JP2007/059922 patent/WO2007135890A1/fr not_active Ceased
- 2007-05-15 AU AU2007252658A patent/AU2007252658B2/en not_active Expired - Fee Related
- 2007-05-15 AT AT07743357T patent/ATE535527T1/de active
- 2007-05-15 EP EP07743357A patent/EP2019103B1/fr not_active Not-in-force
- 2007-05-15 ES ES07743357T patent/ES2376491T3/es active Active
- 2007-05-15 RU RU2008150377/04A patent/RU2008150377A/ru not_active Application Discontinuation
- 2007-05-15 NZ NZ573363A patent/NZ573363A/en not_active IP Right Cessation
- 2007-05-15 CA CA002653783A patent/CA2653783A1/fr not_active Abandoned
-
2008
- 2008-11-19 IL IL195378A patent/IL195378A0/en unknown
- 2008-12-16 NO NO20085265A patent/NO20085265L/no not_active Application Discontinuation
-
2010
- 2010-11-30 IL IL209651A patent/IL209651A0/en unknown
- 2010-11-30 IL IL209650A patent/IL209650A0/en unknown
- 2010-11-30 IL IL209649A patent/IL209649A0/en unknown
-
2012
- 2012-06-29 US US13/537,422 patent/US8506930B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| NZ573363A (en) | 2012-01-12 |
| US20120271053A1 (en) | 2012-10-25 |
| KR20090010987A (ko) | 2009-01-30 |
| RU2008150377A (ru) | 2010-06-27 |
| AU2007252658B2 (en) | 2012-03-29 |
| JPWO2007135890A1 (ja) | 2009-10-01 |
| IL195378A0 (en) | 2011-08-01 |
| IL209649A0 (en) | 2011-02-28 |
| IL209650A0 (en) | 2011-02-28 |
| BRPI0711818A2 (pt) | 2011-12-13 |
| US20090252679A1 (en) | 2009-10-08 |
| EP2019103B1 (fr) | 2011-11-30 |
| US8506930B2 (en) | 2013-08-13 |
| EP2019103A1 (fr) | 2009-01-28 |
| TW200808795A (en) | 2008-02-16 |
| IL209651A0 (en) | 2011-02-28 |
| ATE535527T1 (de) | 2011-12-15 |
| JP5238496B2 (ja) | 2013-07-17 |
| ES2376491T3 (es) | 2012-03-14 |
| CA2653783A1 (fr) | 2007-11-29 |
| US8303935B2 (en) | 2012-11-06 |
| WO2007135890A1 (fr) | 2007-11-29 |
| AU2007252658A1 (en) | 2007-11-29 |
| EP2019103A4 (fr) | 2010-05-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20085265L (no) | Nye forbindelser som har affinitet for amyloid | |
| NO20090233L (no) | Ny sammensetning som har affinitet for amyloid | |
| NO20074718L (no) | BCRP/ABCG2 inhibitor | |
| EA201070323A1 (ru) | Замещенное производное пиразола | |
| NO20084897L (no) | Ny forbindelse med affinitet til amuloid | |
| UA91470C2 (ru) | Нематоцидная композиция, способ борьбы с нематодами и применение производной n-2-(пиридил) этилкарбоксамида в качестве нематоцида | |
| MY153045A (en) | Oxopyrazine derivative and herbicide | |
| BRPI0510305A (pt) | composto ou um sal do mesmo, pródroga ou um sal da mesma, agente farmacêutico, método de produção do composto ou um sal do mesmo, inibidor de metaloproteinase de matriz ou um sal do mesmo ou uma pródroga do mesmo, método de inibir uma metaloproteinase de matriz, e, uso de um composto ou de um sal do mesmo ou de uma pródroga do mesmo | |
| WO2009054497A1 (fr) | Nouveau composé présentant une affinité pour l'amyloïde | |
| TW200732332A (en) | Oxazole compound and pharmaceutical composition | |
| NO20065578L (no) | Substituerte metylaryl eller heteroarylamidforbindelser | |
| NO20076524L (no) | Pyrazolforbindelse samt terapeutisk middel for diabetes som omfatter det samme | |
| NO20092248L (no) | Ny forbindelse med affinitet for amyloid | |
| WO2009054496A1 (fr) | Nouveau composé possédant une affinité vis-à-vis d'une substance amyloïde | |
| DK1961734T3 (da) | Aminforbindelse og anvendelse deraf til medicinske formål | |
| NO20082698L (no) | Nye derivater, deres salter og antisoppmidler inneholdende disse | |
| CY1111653T1 (el) | Φαρμακευτικη συνθεση περιεχουσα παραγωγα 2,3-διυδρο-6-νιτροϊμιδαζο [2,1-β] οξαζολιου | |
| WO2009057576A1 (fr) | Utilisation d'un nouveau composé présentant une affinité pour les substances amyloïdes et procédé de production dudit composé | |
| UA97370C2 (ru) | Производные фенилпентадиеноила и их применение в качестве антагонистов par 1 | |
| MX2007004643A (es) | Derivado de 1,5-diheterociclo-1h-triazol. | |
| MEP27108A (en) | 3-(pyridin-2-yl)-[1,2,4]-triazines for use as fungicides | |
| TW200801016A (en) | Thienopyridine-2-carboxamide derivatives | |
| TH94272A (th) | สารประกอบ | |
| TH95735A (th) | อนุพันธ์ 3-ซัลโฟนิลอินดาโซลที่ถูกแทนที่เป็นลิแกนด์ 5-ไฮดรอกซีทริปทามีน-6 | |
| TH88755B (th) | สารประกอบทางเคมี |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |